Co-beneldopa (Benserazide/levodopa) vs Botulinum toxin type A
National NHS prescribing compared (Prescription Cost Analysis)
Co-beneldopa (Benserazide/levodopa) was dispensed 2,979.8× as often as Botulinum toxin type A in May 2026 — 77,476 items versus 26 in England.
77,476items
Co-beneldopa (Benserazide/levodopa) · May 2026
NHSBSA Prescription Cost Analysis
26items
Botulinum toxin type A · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Co-beneldopa (Benserazide/levodopa) versus Botulinum toxin type A: national items dispensed by month
▬ Co-beneldopa (Benserazide/levodopa) · ╌ Botulinum toxin type A
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Co-beneldopa (Benserazide/levodopa) | Botulinum toxin type A |
|---|---|---|
| Items, May 2026 | 77,476 | 26 |
| Items, last 12 months | 948,791 | 211 |
| Net ingredient cost, May 2026 | £953,642 | £4,749 |
See the full profile for Co-beneldopa (Benserazide/levodopa) or Botulinum toxin type A.